Evidence map›Paper›PMID 40625869›Full record

ArticleHealth affairs scholar2025

Geographic variation in Medicare Advantage nonemergency medical transportation benefits 2020-2024.

Chuan Angel Lu, Lesi He, Arthur S Hong, Megan A Mullins, Joshua M Liao, Changchuan Jiang

Abstract read
In one paragraph

Article in Health affairs scholar, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chuan Angel LuDivision of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.ORCID https://orcid.org/0009-0004-7479-6803
Lesi HeDepartment of Health Data Science and Biostatistics, Peter J. O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.ORCID https://orcid.org/0009-0001-5732-4220
Arthur S HongDepartment of Health Economics, Systems, & Policy Peter J. O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.ORCID https://orcid.org/0000-0001-6516-6819
Megan A MullinsDepartment of Health Economics, Systems, & Policy Peter J. O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.ORCID https://orcid.org/0000-0003-2753-9068
Joshua M LiaoDepartment of Health Economics, Systems, & Policy Peter J. O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.
Changchuan JiangDivision of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.ORCID https://orcid.org/0000-0002-7392-4154

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Nonemergency medical transportation (NEMT) is a supplemental benefit in Medicare Advantage (MA) plans that helps individuals overcome transportation barriers to healthcare services. It remains unclear whether these benefits are targeted to communities with greater needs. Methods: We analyzed MA plan benefit data from 2020 to 2024 across 2764 US counties. Transportation barriers were assessed using 5 indicators: vehicle ownership, income levels, self-reported health status, avoidable hospital visits, and access to primary care. We examined trends in NEMT availability and its alignment with county-level transportation need, considering MA plan penetration as a modifying factor. Results: Nonemergency medical transportation benefit prevalence in MA plans increased by 13.88% points from 2020 to 2024. In 2024, counties with the greatest transportation barriers had a 19.4% point higher prevalence of NEMT offerings compared to counties with the fewest barriers. Alignment was stronger in counties with higher MA plan penetration. Conclusion: Medicare Advantage plans increasingly offer NEMT benefits in areas with greater transportation challenges, especially where MA plan penetration is higher. These findings suggest responsiveness to social needs and the potential role of market dynamics. Policymakers can support equitable access by incorporating transportation needs into MA plan evaluations.

Indexed as

access to carehealthcare accesshealthcare disparitieshealth equityMA penetrationMedicare Advantage (MA)nonemergency medical transportation (NEMT)policy implicationsocial determinants of healthsocial needssupplemental benefitstransportation barriers to caretransportation challenges

Identifiers

PMID40625869
PMCPMC12231549

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.